Marker Therapeutics (MRKR) Short Interest Ratio & Short Volume $3.66 -0.39 (-9.63%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Marker Therapeutics Short Interest DataMarker Therapeutics (MRKR) has a short interest of 61,300 shares, representing 0.95% of the float (the number of shares available for trading by the public). This marks a 9.86% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 51,075 shares to cover all short positions.Current Short Interest61,300 sharesPrevious Short Interest55,800 sharesChange Vs. Previous Month+9.86%Dollar Volume Sold Short$200,451.00Short Interest Ratio1.7 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares8,920,000 sharesFloat Size6,450,000 sharesShort Percent of Float0.95%Today's Trading Volume37,727 sharesAverage Trading Volume51,075 sharesToday's Volume Vs. Average74% Short Selling Marker Therapeutics? Sign up to receive the latest short interest report for Marker Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRKR Short Interest Over TimeMRKR Days to Cover Over TimeMRKR Percentage of Float Shorted Over Time Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Marker Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202461,300 shares $200,451.00 +9.9%1.0%1.7 $3.27 9/30/202455,800 shares $157,356.00 -13.9%0.9%2.2 $2.82 9/15/202464,800 shares $179,781.12 -22.7%1.0%2.4 $2.77 8/31/202483,800 shares $302,518.00 +3.3%1.3%2.7 $3.61 8/15/202481,100 shares $257,898.00 -17.8%1.3%3 $3.18 7/31/202498,600 shares $482,154.00 -2.2%1.5%4.4 $4.89 Get the Latest News and Ratings for MRKR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024100,800 shares $561,456.00 -14.0%1.6%4.7 $5.57 6/30/2024117,200 shares $636,396.00 +25.6%1.8%5.9 $5.43 6/15/202493,300 shares $388,566.51 +58.1%1.5%4.6 $4.16 5/31/202459,000 shares $228,330.00 +17.1%0.9%3.5 $3.87 5/15/202450,400 shares $210,168.00 -6.5%0.8%3 $4.17 4/30/202453,900 shares $218,295.00 -16.3%0.8%3 $4.05 4/15/202464,400 shares $285,936.00 -40.3%1.0%3.4 $4.44 3/31/2024107,900 shares $463,970.00 -27.9%1.7%5.1 $4.30 3/15/2024149,700 shares $663,171.00 -7.0%2.3%6 $4.43 2/29/2024160,900 shares $584,067.00 -9.6%2.5%2 $3.63 2/15/2024177,900 shares $752,517.00 +1.1%2.8%2.2 $4.23 1/31/2024175,900 shares $816,176.00 -12.7%2.7%2.2 $4.64 1/15/2024201,400 shares $970,748.00 -14.5%3.1%2.5 $4.82 12/31/2023235,500 shares $1.30 million -10.9%3.7%2.9 $5.50 12/15/2023264,300 shares $1.24 million +56.0%4.1%3.3 $4.70 11/30/2023169,400 shares $467,544.00 -18.1%2.7%2.3 $2.76 11/15/2023206,900 shares $577,251.00 -3.9%3.2%5.6 $2.79 10/31/2023215,200 shares $516,480.00 -7.8%3.4%4.6 $2.40 10/15/2023233,400 shares $772,554.00 -10.0%3.7%2.7 $3.31 9/30/2023259,200 shares $1.18 million -16.5%4.1%2.2 $4.54 9/15/2023310,300 shares $1.66 million +65.8%4.9%2.2 $5.36 8/31/2023187,200 shares $1.05 million -11.3%3.0%0.9 $5.62 8/15/2023211,000 shares $1.24 million -23.1%3.3%0.3 $5.86 7/31/2023274,200 shares $1.38 million +43.3%4.4%0.3 $5.05 7/15/2023191,300 shares $1.01 million -41.1%3.0%0.2 $5.26 6/30/2023325,000 shares $1.01 million -28.8%5.2%0.4 $3.10 6/15/2023456,500 shares $1.13 million +478.6%7.2%0.6 $2.48 5/31/202378,900 shares $140,442.00 -26.3%1.3%0.1 $1.78 5/15/2023107,000 shares $146,590.00 -51.0%1.7%0.8 $1.37 4/30/2023218,400 shares $183,761.76 +1,169.8%3.0%1.6 $0.84 4/15/202317,200 shares $18,920.00 +91.1%0.2%0.2 $1.10 3/31/20239,000 shares $6,390.00 -90.0%0.1%0.2 $0.71 3/15/202389,900 shares $178,002.00 +37.5%1.2%1.7 $1.98 2/28/202365,400 shares $141,918.00 +64.3%0.9%1.7 $2.17I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 2/15/202339,800 shares $89,948.00 -18.3%0.6%1 $2.26 1/31/202348,700 shares $136,360.00 -93.7%0.8%1.2 $2.80 1/15/2023767,400 shares $272,503.74 +30.8%1.2%2.6 $0.36 12/30/2022586,600 shares $155,976.35 -21.4%1.0%1.9 $0.27 12/15/2022745,800 shares $222,621.30 -11.6%1.3%2.7 $0.30 11/30/2022843,800 shares $253,140.00 -14.7%1.4%2.5 $0.30 11/15/2022989,100 shares $343,514.43 -16.9%1.7%2 $0.35 10/31/20221,190,000 shares $528,003.00 +21.5%2.0%2.2 $0.44 10/15/2022979,200 shares $381,888.00 -16.3%1.7%0.5 $0.39 9/30/20221,170,000 shares $431,496.00 -6.4%4.3%0.6 $0.37 9/15/20221,250,000 shares $573,125.00 -9.4%4.6%0.6 $0.46 8/31/20221,380,000 shares $427,800.00 -14.3%5.1%0.7 $0.31 8/15/20221,610,000 shares $643,034.00 +87.8%5.9%0.9 $0.40 7/31/2022857,100 shares $273,414.90 -23.5%3.1%0.5 $0.32 7/15/20221,120,000 shares $374,080.00 +6.7%4.1%4.1 $0.33 6/30/20221,050,000 shares $346,500.00 -13.2%3.9%3.5 $0.33 6/15/20221,210,000 shares $326,700.00 -8.3%4.4%3.9 $0.27 5/31/20221,320,000 shares $398,640.00 -10.2%2.3%3.9 $0.30 5/15/20221,470,000 shares $484,218.00 No Change2.6%3.7 $0.33 4/30/20221,470,000 shares $498,330.00 -2.7%2.6%3.2 $0.34 4/15/20221,510,000 shares $610,040.00 +24.8%2.7%2.9 $0.40 3/31/20221,210,000 shares $532,400.00 -42.1%2.2%1.7 $0.44 3/15/20222,090,000 shares $836,000.00 +26.7%3.7%2.8 $0.40 2/28/20221,650,000 shares $620,565.00 +3.8%2.9%2.2 $0.38 2/15/20221,590,000 shares $935,397.00 -7.6%2.8%2.1 $0.59 1/31/20221,720,000 shares $1.04 million +84.6%3.0%2.4 $0.61 1/15/2022931,700 shares $753,093.11 -9.5%1.7%1.4 $0.81 12/31/20211,030,000 shares $978,500.00 +6.3%1.8%2.4 $0.95 12/15/2021968,900 shares $968,900.00 -14.3%1.7%2.3 $1.00 11/30/20211,130,000 shares $1.33 million No Change2.0%3 $1.18 11/15/20211,130,000 shares $1.58 million -5.0%2.0%3.4 $1.40 10/29/20211,190,000 shares $1.75 million No Change2.1%2.6 $1.47 10/15/20211,190,000 shares $1.89 million -8.5%2.1%2.5 $1.59 9/30/20211,300,000 shares $2.20 million -3.7%2.3%2.6 $1.69 9/15/20211,350,000 shares $2.46 million -3.6%2.4%2.2 $1.82 8/31/20211,400,000 shares $2.77 million -3.5%2.5%1.9 $1.98 8/13/20211,450,000 shares $2.77 million -1.4%2.6%1.5 $1.91 7/30/20211,470,000 shares $3.07 million +52.3%2.6%1.3 $2.09 7/15/2021965,500 shares $2.12 million -21.5%1.7%0.7 $2.20 6/30/20211,230,000 shares $3.43 million -47.0%2.2%0.8 $2.79 6/15/20212,320,000 shares $7.48 million -2.5%4.1%1.2 $3.23 5/28/20212,380,000 shares $6.93 million -11.5%4.2%0.6 $2.91 5/14/20212,690,000 shares $5.60 million -6.9%4.8%0.7 $2.08 4/30/20212,890,000 shares $7.75 million -7.4%5.2%0.8 $2.68 4/15/20213,120,000 shares $6.61 million -5.2%5.9%0.9 $2.12 3/31/20213,290,000 shares $7.11 million -5.7%9.2%1 $2.16 3/15/20213,490,000 shares $6.77 million +7.4%9.9%1.2 $1.94 2/26/20213,250,000 shares $8.00 million -3.9%10.0%5.5 $2.46 2/12/20213,380,000 shares $10.34 million +5.3%10.4%5.9 $3.06 1/29/20213,210,000 shares $5.78 million -4.5%9.8%6 $1.80I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 1/15/20213,360,000 shares $7.16 million No Change10.3%7.9 $2.13 1/31/20204,890,000 shares $12.67 million No Change55.1%13.5 $2.59 1/15/20204,890,000 shares $14.96 million No Change55.1%13.5 $3.06 12/31/20194,890,000 shares $14.03 million -3.4%55.1%13.9 $2.87 MRKR Short Interest - Frequently Asked Questions What is Marker Therapeutics' current short interest? Short interest is the volume of Marker Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 61,300 shares of MRKR short. 0.95% of Marker Therapeutics' shares are currently sold short. Learn More on Marker Therapeutics' current short interest. What is a good short interest ratio for Marker Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRKR shares currently have a short interest ratio of 2.0. Learn More on Marker Therapeutics's short interest ratio. What is a good short interest percentage for Marker Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.95% of Marker Therapeutics' floating shares are currently sold short. Is Marker Therapeutics' short interest increasing or decreasing? Marker Therapeutics saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 61,300 shares, an increase of 9.9% from the previous total of 55,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Marker Therapeutics' float size? Marker Therapeutics currently has issued a total of 8,920,000 shares. Some of Marker Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Marker Therapeutics currently has a public float of 6,450,000 shares. How does Marker Therapeutics' short interest compare to its competitors? 0.95% of Marker Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Marker Therapeutics: Telomir Pharmaceuticals, Inc. (3.40%), Cardiff Oncology, Inc. (15.73%), FitLife Brands, Inc. (0.25%), Eledon Pharmaceuticals, Inc. (0.36%), Incannex Healthcare Inc. (0.53%), Vaxart, Inc. (6.61%), Inventiva S.A. (1.63%), Brainstorm Cell Therapeutics Inc. (3.43%), Innate Pharma S.A. (0.07%), Checkpoint Therapeutics, Inc. (12.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Marker Therapeutics stock? Short selling MRKR is an investing strategy that aims to generate trading profit from Marker Therapeutics as its price is falling. MRKR shares are trading down $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Marker Therapeutics? A short squeeze for Marker Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRKR, which in turn drives the price of the stock up even further. How often is Marker Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRKR, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies TELO Short Squeeze CRDF Short Squeeze FTLF Short Squeeze ELDN Short Squeeze IXHL Short Squeeze VXRT Short Squeeze IVA Short Squeeze BCLI Short Squeeze IPHA Short Squeeze CKPT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRKR) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marker Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marker Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
